Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine. [su_expand more_text=”Show more” less_text=”Show less” height=”100″ hide_less=”no” text_color=”#333333″ link_color=”#0088FF” link_style=”default” link_align=”left” more_icon=”” less_icon=”” class=””]
GR-1®/RC-14® and VAGINAL FLORA (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1®/RC-14® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
[/su_expand]
Supplement Facts
- Serving Size1 Capsule
- Servings Per Container60
- Calories0
- Calories from Fat0
- Food ComponentAmount/Serving% Daily Value*
- Total Probiotic Blend Composed of the following strains: Lactobacillus rhamnosus, GR-1 Lactobacillus reuteri, RC-141 Billion Viable Cells (Minimum)§
Reviews
There are no reviews yet.